SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-074571
Filing Date
2024-06-25
Accepted
2024-06-25 08:21:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2417784d1_424b5.htm 424B5 468671
2 GRAPHIC tm2417784d1_424b5img001.jpg GRAPHIC 16501
3 GRAPHIC tm2417784d1_424b5-img01.jpg GRAPHIC 3445
4 GRAPHIC tm2417784d1_424b5001.jpg GRAPHIC 11632
  Complete submission text file 0001104659-24-074571.txt   513813
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278646 | Film No.: 241066192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)